Welcome to Pneumolabs
Pneumolabs provides high quality contract research services to progress compounds from hit identification through to lead optimization in disease models. We have numerous scientific publications and success with compounds reaching clinical evaluation.
Our greatest asset is our people, and we have a wealth of experience in the Pharmaceutical industry. This enables us to advise our clients on the best model for their desired outcome, and tailor our services to ensure maximal success, and a rapid and efficient service.
Get In Touch
For further information about our services, or to discuss setting up a new disease model, please contact us using the details below.
Our latest research model involves exposure to the protein from the fungal allergen Alternaria alternata. Data to follow shortly.
Inflammatory diseases are increasing in prevalence around the globe and affect millions of people annually, and so, stemming from our initial expertise in respiratory disease, our models have expanded to cover a broad spectrum of inflammatory based conditions.
We can offer a variety of research models in the field of inflammation, such as respiratory, gastrointestinal and ocular diseases, as well as models of infection, and pharmacokinetic screening.
We are always open to discussing new models specific to your requirements.
- Pulmonary infection
- PK Screening
- Ulcerative Colitis/ Intestinal Fibrosis
- Pulmonary Hypertension
- Pulmonary Fibrosis
- Nasal inflammation
- Fungal-induced lung inflammation
- Ozone-induced lung inflammation
- Acute lung injury
- Severe asthma (HDM)
- Asthma exacerbation (Alternaria)
- Asthma exacerbation (influenza)
- Asthma (steroid sensitive)